Bachrodt Amy
SVP, Finance
Bachrodt Amy has filed 6 SEC Form 4 filings (25 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Apr 2, 2026.
On the most recent filing, Bachrodt Amy is listed as SVP, Finance at Maze Therapeutics, Inc. Inside the rolling window, Bachrodt Amy reported no open-market purchases and 7 open-market sales totaling $1.6M in MAZE. The largest disclosed transaction in the window is a sale of 10,000 MAZE shares on Dec 29, 2025, worth $406K.
Companies traded
Other insiders at MAZE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bachrodt Amy made?
Bachrodt Amy has filed 6 SEC Form 4 filings (25 transaction rows) across 1 company since 2025.
Which companies does Bachrodt Amy trade?
Bachrodt Amy has filed SEC Form 4 disclosures for 1 company, including MAZE.
When was Bachrodt Amy's most recent SEC Form 4 filing?
Bachrodt Amy's most recent SEC Form 4 filing on Tracefour is dated Apr 2, 2026.
What is Bachrodt Amy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bachrodt Amy is listed as SVP, Finance.
What is Bachrodt Amy's total buy and sell value in the current window?
Inside the rolling retention window, Bachrodt Amy bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Bachrodt Amy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 MAZE shares on 2025-12-29, worth $406K, per SEC Form 4 filings.